Contact this trialFirst, we need to learn more about you.
Farnesoid X receptor agonist
Seladelpar for Primary Biliary Cholangitis
Recruiting1 awardPhase 3
Redwood City, California
This trial will study if a new drug, Seladelpar, can help treat PBC, a liver disease, in people who have not fully responded to other treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.